DH · XBRL financial data

Definitive Healthcare financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (DH's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	65	66*	63	64	63	62*	59	61	60	62*	56	55
Cost of revenue	—	year only	13	13	14	15*	15	14	14	15*	14	15
Gross profit	53	—	50	50	49	48*	44	47	46	47*	42	41
Research and development	11	12*	10	10	7	9*	9	8	8	10*	6	7
General and administrative	15	17*	17	13	11	9*	12	13	12	14*	12	11
Total operating expenses	349	63*	67	420	274	147*	229	51	55	74*	243	47
Operating income (loss)	(295)	(10)*	(16)	(370)	(225)	(100)*	(185)	(4)	(9)	(27)*	(201)	(7)
Interest expense	4	4*	4	4	4	4*	2	3	3	3*	3	3
Other income (expense)	29	(2)*	3	42	24	9*	19	(5)	(9)	9*	6	(1)
Income tax expense (benefit)	(18)	1*	(1)	(22)	(14)	(6)*	(11)	0	1	(0)*	(3)	(0)
Net income (loss)	(172)	(10)*	(10)	(214)	(131)	(59)*	(107)	(8)	(15)	(9)*	(139)	(5)
Earnings per share, basic USD per share	(1.50)	(0.09)*	(0.08)	(1.81)	(1.12)	(0.51)*	(0.95)	(0.07)	(0.14)	(0.09)*	(1.32)	(0.05)
Earnings per share, diluted USD per share	(1.50)	(0.09)*	(0.08)	(1.81)	(1.12)	(0.51)*	(0.95)	(0.07)	(0.14)	(0.09)*	(1.32)	(0.05)
Weighted average shares, basic millions of shares	115	116*	117	118	116	115*	113	107	104	103*	105	106
Weighted average shares, diluted millions of shares	115	116*	117	118	116	115*	113	107	104	103*	105	106

Fiscal quarters (DH's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	77	131	106	121	138	105	106	81	108	164	158	171
Short-term investments	230	177	189	176	168	185	95	103	78	17	20	13
Accounts receivable	41	59	57	44	36	53	43	38	34	52	39	31
Prepaid and other current assets	15	13	13	14	14	13	16	14	13	12	16	13
Total current assets	375	394	379	368	369	370	273	249	246	258	246	240
Property and equipment, net	5	4	4	4	4	4	9	11	12	13	14	15
Right-of-use asset	10	10	9	8	8	8	7	7	6	5	5	4
Goodwill	1,074	1,075	1,082	718	490	393	217	217	217	197	0	0
Total assets	1,820	1,826	1,810	1,422	1,182	1,089	809	770	756	735	515	497
Accounts payable	6	6	5	6	10	11	8	8	9	4	6	5
Accrued liabilities	36	52	36	34	36	41	27	31	42	45	24	24
Current portion of long-term debt	14	14	14	14	14	14	9	9	9	9	9	9
Total current liabilities	147	171	165	153	148	161	156	151	154	157	140	129
Long-term debt	246	243	239	236	233	229	162	160	158	156	154	152
Lease liability, non-current	10	9	9	8	8	8	7	6	6	5	4	4
Total liabilities	616	627	615	536	486	482	373	359	366	357	324	309
Accumulated deficit	(217)	(227)	(237)	(451)	(581)	(641)	(748)	(755)	(770)	(780)	(918)	(924)
Total liabilities and equity	1,820	1,826	1,810	1,422	1,182	1,089	809	770	756	735	515	497
Common shares outstanding (cover page) millions of shares	116	118	118	117	116	113	107	104	103	104	106	107

Fiscal quarters (DH's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(172)	(10)*	(10)	(214)	(131)	(59)*	(107)	(8)	(15)	(9)*	(139)	(5)
Stock-based compensation	12*	13*	16	9*	6*	7*	7	7*	7*	8*	5	5*
Depreciation and amortization	0*	1*	1	1*	1*	1*	1	1*	1*	1*	1	1*
Net cash from operating activities	9*	5*	17	14*	19*	8*	26	9*	16*	3*	12	11*
Purchases of property and equipment	0*	1*	0	0*	1*	11*	8	2*	2*	4*	3	3*
Net cash from investing activities	(54)*	54*	(24)	15*	9*	(26)*	84	(10)*	24*	56*	(6)	5*
Proceeds from issuing common stock	—	year only	—	—	—	—	—	—	—	—	—	—
Share repurchases	0*	0*	0	7*	8*	7*	21	19*	9*	0*	0	0*
Proceeds from long-term debt	—	year only	—	—	—	—	—	—	—	—	—	—
Repayments of long-term debt	2*	3*	3	3*	3*	3*	246	2*	2*	2*	2	2*
Net cash from financing activities	(10)*	(6)*	(17)	(14)*	(12)*	(13)*	(110)	(25)*	(12)*	(4)*	(11)	(3)*

SIC 7372 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 7372 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Definitive Healthcare	171	55	11*	106.7M	—	Q2 FY26 10-QJun 30, 2026
CS Disco	13	45	(3)*	65.7M	14.5 quarters	Q3 FY26 10-QSep 30, 2026
ReposiTrak	27	not reported	2.4*	18.2M	—	Q4 FY26 10-KJun 30, 2026
Telos	51	48	8.8*	74.7M	—	Q2 FY26 10-QJun 30, 2026
On24	37	35*	(1.1)*	42.9M	158.0 quarters	Q4 FY25 10-KDec 31, 2025
HawkEye 360	503	50	12*	98.0M	—	Q2 FY26 10-QJun 30, 2026
Expensify	66	34	8.4*	not reported	—	Q2 FY26 10-QJun 30, 2026
Tucows	44	not reported	1.9	11.2M	—	Q2 FY26 10-QJun 30, 2026
Rackspace Technology	111	670	(32)*	254.9M	3.5 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.